STANFORD, Calif. - A new analysis has found that many alcohol treatment studies are designed in ways that inadvertently omit women and African-Americans from participation. The Stanford University School of Medicine researcher who led the effort said the findings should remind all scientists that strict study eligibility criteria can have unintended, negative consequences.
In reviewing data from a pool of 100,000 alcohol treatment patients, Keith Humphreys, PhD, professor of psychiatry and behavioral sciences, determined that women and African-Americans were substantially more likely to be excluded from treatment studies than men or non-African-American patients, because of eligibility requirements involving psychiatric problems, employment and housing problems, and drug use.
"Researchers' own study designs are thwarting their good-faith efforts to recruit representative patient samples," said Humphreys, whose paper will be published in the June issue of Alcoholism: Clinical and Experimental Research. "If we want health-care practice to be guided by research, we're going to have to do a better job at studying patients that clinicians actually see."
Medical studies typically exclude certain patients from participation. While some exclusions are often necessary - to protect patient safety, for example - Humphreys suspects researchers often use exclusions in their studies out of habit or tradition. In other cases, researchers may use eligibility criteria to enroll only "desirable" patients in their study, in an effort to make the trial run smoothly or to increase the chances that a favored treatment will show positive outcomes.
Humphreys said such exclusions could have dangerous implications. "If
treatments are tested on, and developed for, only part of the
population, that means everyone excluded is at greater risk when they
use health care," said H
Contact: Michelle Brandt
Stanford University Medical Center